Resistance from antagonistic muscle groups might be a crucial factor reducing function in chronic hemiparesis. The resistance due to spastic co-contraction might be reduced by botulinum toxin injections. We assessed the effects of abobotulinumtoxinA injection in the upper limb muscles on muscle tone, spasticity, active movement, and function.

Gracies, J., Brashear, A., Jech, R., Mcallister, P., Banach, M., Valkovic, P., Walker, H., Marciniak, C., Deltombe, T., Skoromets, A., Khatkova, S., Edgley, S., Gul, F., Catus, F., De Fer, B., Vilain, C., Picaut, P., Ayyoub, Z., Banach, M., Bensmail, D., Bentivoglio, A. R., Boyer, F., Brashear, A., Csanyi, A., Deltombe, T., Denes, Z., Edgley, S., Gul, F., Gracies, J., Hedera, P., Isaacson, S., Isner Horobeti, M., Jech, R., Kaminska, A., Khatkova, S., Kocer, S., Lejeune, T., Mcallister, P., Marciniak, C., Marque, P., O'dell, M., Remy Neris, O., Rubin, B., Rudzinska, M., Simpson, D., Skoromets, A., Timerbaeva, S., Valkovic, P., Vecchio, M., Walker, H., Wimmer, M., Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial, <<THE LANCET>>, 2015; 14 (10): 992-1001. [doi:10.1016/S1474-4422(15)00216-1] [http://hdl.handle.net/10807/69797]

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial

Bentivoglio, Anna Rita;
2015

Abstract

Resistance from antagonistic muscle groups might be a crucial factor reducing function in chronic hemiparesis. The resistance due to spastic co-contraction might be reduced by botulinum toxin injections. We assessed the effects of abobotulinumtoxinA injection in the upper limb muscles on muscle tone, spasticity, active movement, and function.
Inglese
Gracies, J., Brashear, A., Jech, R., Mcallister, P., Banach, M., Valkovic, P., Walker, H., Marciniak, C., Deltombe, T., Skoromets, A., Khatkova, S., Edgley, S., Gul, F., Catus, F., De Fer, B., Vilain, C., Picaut, P., Ayyoub, Z., Banach, M., Bensmail, D., Bentivoglio, A. R., Boyer, F., Brashear, A., Csanyi, A., Deltombe, T., Denes, Z., Edgley, S., Gul, F., Gracies, J., Hedera, P., Isaacson, S., Isner Horobeti, M., Jech, R., Kaminska, A., Khatkova, S., Kocer, S., Lejeune, T., Mcallister, P., Marciniak, C., Marque, P., O'dell, M., Remy Neris, O., Rubin, B., Rudzinska, M., Simpson, D., Skoromets, A., Timerbaeva, S., Valkovic, P., Vecchio, M., Walker, H., Wimmer, M., Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial, <<THE LANCET>>, 2015; 14 (10): 992-1001. [doi:10.1016/S1474-4422(15)00216-1] [http://hdl.handle.net/10807/69797]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/69797
Citazioni
  • ???jsp.display-item.citation.pmc??? 50
  • Scopus 119
  • ???jsp.display-item.citation.isi??? 102
social impact